165 - Anatomy of a Target Product Profile(TPP): All 10 Sections EXPLAINED with Marta New

Let's Combinate · 4 Dec 2024 · 1h 10m

What this episode covers

Marta New, CEO of Radyus Research, explains the anatomy of a Target Product Profile (TPP), a strategic document that aligns clinical, regulatory, and commercial goals early in drug development. She details the 10 critical sections of a TPP, including target indication, efficacy benchmarks, safety/toxicology thresholds, and go/no-go criteria, emphasizing that it serves as a roadmap from discovery to development. New highlights how integrating these elements early prevents costly failures and ensures that manufacturing, quality, and regulatory strategies are aligned with the final product's label.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 41m

    How to Construct an Effective Regulatory Strategy

    Mike Drues of Vascular Sciences, joined by host Jon Speer of Greenlight Guru, explains that a regulatory strategy is a dynamic communication tool, not merely a pathway like 510(k) or De Novo. Drues details the components of a Regulatory Strategy Executive Summary, including device description, labeling matrix, classification, risk assessment, and potential pathways, emphasizing its use in investor pitch decks and internal stakeholder buy-in. The discussion highlights the importance of bringing regulatory experts in early to avoid costly design changes and demonstrates how to balance short-term speed with long-term strategic goals using a 'future features list.'

  • Global Medical Device Podcast · 36m

    How to Establish a Solid Foundation for Fundraising and Product Success by Focusing on Regulatory

    Isabella Schmitt, a regulatory affairs consultant at Proxima Clinical Research, joins host John Spear to discuss how a strong regulatory strategy underpins fundraising and product success for medical device companies. Schmitt advises startups to avoid starting with technology without a clear problem, emphasizing the importance of Minimum Viable Products (MVPs) and design controls to prevent perpetual iteration. She highlights the '1/10/100 rule' to illustrate how early validation reduces costs and increases company value by hitting major milestones like animal studies or clinical trials. The conversation also covers selecting regulatory pathways (PMA vs. 510(k)) based on market size and reimbursement, and navigating current global regulatory landscapes like the EU MDR and FDA requirements.

  • Global Medical Device Podcast · 40m

    #364: Building a Partnership with your Regulatory Consultant

    Christine Luk, Associate Regulatory Affairs Manager at Proxima, shares her journey from a failed women's health startup to navigating FDA regulatory pathways. She details the critical importance of aligning with regulatory consultants early, managing time-and-materials budgets, and structuring effective FDA interactions like pre-submissions. Luk emphasizes that founders must provide clear design inputs and roadmap context to avoid costly pivots and ensure efficient market entry.

  • IDology · 1h 00m

    IDology #9 - NASAs TRL scale in product development

    Voytek and Mikołaj from the industrial design studio Mindsailors discuss adapting NASA's Technology Readiness Level (TRL) scale for product development to manage client expectations and clarify the definition of 'prototype'. They walk through the nine stages, explaining how TRL 1-3 covers initial concepts and proof of concept, while TRL 4-6 involves testing components and systems in relevant environments. The conversation highlights the transition from laboratory validation to real-world user testing at TRL 7-8, culminating in a 'golden sample' or MVP that is ready for manufacturing tooling.

  • The Startup CPG Podcast · 23m

    We're launching Founders & Formulators - Here's Why

    Daniel Scharff and Adam Yee discuss the launch of Startup CPG's 'Founders & Formulators' event in Chicago and the accompanying Product Developer Directory. Yee explains how formulators evaluate products through 'vibes' and technical inquiry, emphasizing the need for clear deliverables to avoid scope disputes. They highlight the directory as a tool for vetting consultants based on specialty, fee structure, and past work.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.